September 10, 2026
Eleventh Circuit Rejects Constitutional Challenge to FCA Qui Tam Provisions
Last week, in United States ex rel. Zafirov v. Florida Medical Associates, LLC, the Eleventh Circuit rejected a constitutional challenge to the False Claims Act’s (“FCA”) qui tam provisions, reversing...
Posted In Whistleblower Law Insights
September 03, 2026
Pharmaceutical Whistleblower & Fraud Cases
A pharmaceutical whistleblower is someone who reports suspected fraud or misconduct involving a drug manufacturer, pharmacy, pharmaceutical distributor, pharmacy benefit manager (PBM), or another organization...
AI Whistleblowers: Reporting AI Fraud and Misconduct
Artificial Intelligence (“AI”) pervades current discussions in government, business, and academia. While the potential for this rapidly developing technology is both exciting and unnerving, some...
Posted In Whistleblower Law Insights
September 02, 2026
Ruling Affirms the False Claims Act does not violate the Appointments Clause of Article II of the Constitution
Phillips & Cohen Statement RE: United States ex rel. Zafirov v. Florida Medical Associates, Inc. Yesterday, in United States ex rel. Zafirov v. Florida Medical Associates, Inc., the Eleventh Circuit...
Posted In Phillips & Cohen News